Amanpal Singh1, Yong-Fang Kuo, Taylor S Riall, G S Raju, James S Goodwin. 1. Division of Gastroenterology, Department of Internal Medicine, University of Texas Medical Branch (UTMB), 301 University Blvd., Galveston, TX 77555-0764, USA. amasingh@utmb.edu
Abstract
BACKGROUND: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. METHODS: A 5% national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. RESULTS: Among 200,857 patients (mean age 74 years, 61% female, 92% White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. CONCLUSIONS: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.
BACKGROUND: The incidence of colorectal cancer following a normal colonoscopy in the Medicare population is not known. METHODS: A 5% national sample of Medicare enrollees from 1996 to 2005 was used to identify patients undergoing complete colonoscopy. A colonoscopy not associated with any procedure (e.g., biopsy, polypectomy or fulguration) was defined as a negative colonoscopy. Patients with history of inflammatory bowel disease, colorectal cancer or death within 12 months of colonoscopy were excluded. A multivariable model was constructed to evaluate the factors associated with a new diagnosis of colorectal cancer in the period from 12 to 120 months following the negative colonoscopy. RESULTS: Among 200,857 patients (mean age 74 years, 61% female, 92% White) with a negative colonoscopy, the incidence of colorectal cancer was 1.8 per 1,000 person-years. The incidence rate for matched follow-up periods decreased from 2.0/1,000 person-years for patients undergoing colonoscopy during 1996-2000 to 1.2/1,000 person years during 2001-2005. Multivariate analysis revealed a significant regional variation in the incidence of colorectal cancer following a negative colonoscopy. The incidence was higher in patients >85 years, males and patients who underwent a negative colonoscopy by a non-gastroenterologist or endoscopist in the lowest volume quartile. On stratified analyses, endoscopist volume was a significant predictor for non-gastroenterologists only. CONCLUSIONS: The specialty and experience of the endoscopist are significant predictors of the incidence rate of colorectal cancer in Medicare patients with a negative colonoscopy.
Authors: D K Rex; O W Cummings; D J Helper; T V Nowak; J M McGill; G Z Chiao; P Y Kwo; K T Gottlieb; S O Ikenberry; F G Gress; G A Lehman; L J Born Journal: Gastroenterology Date: 1996-11 Impact factor: 22.682
Authors: Perry J Pickhardt; Pamela A Nugent; Pauline A Mysliwiec; J Richard Choi; William R Schindler Journal: Ann Intern Med Date: 2004-09-07 Impact factor: 25.391
Authors: Ann Chao; Cari J Connell; Vilma Cokkinides; Eric J Jacobs; Eugenia E Calle; Michael J Thun Journal: Am J Public Health Date: 2004-10 Impact factor: 9.308
Authors: Devang N Prajapati; Kia Saeian; David G Binion; David M Staff; Joseph P Kim; Benson T Massey; Walter J Hogan Journal: Am J Gastroenterol Date: 2003-01 Impact factor: 10.864
Authors: Amandeep K Shergill; Erin E Conners; Kenneth R McQuaid; Sara Epstein; James C Ryan; Janak N Shah; John Inadomi; Ma Somsouk Journal: Gastrointest Endosc Date: 2015-05-01 Impact factor: 9.427
Authors: Jennifer L Holub; Cynthia Morris; Lyle J Fagnan; Judith R Logan; LeAnn C Michaels; David A Lieberman Journal: J Rural Health Date: 2017-01-03 Impact factor: 4.333
Authors: David I Fudman; Charles J Lightdale; John M Poneros; Gregory G Ginsberg; Gary W Falk; Maureen Demarshall; Milli Gupta; Prasad G Iyer; Lori Lutzke; Kenneth K Wang; Julian A Abrams Journal: Gastrointest Endosc Date: 2014-02-22 Impact factor: 9.427
Authors: Kristin M Sheffield; Yimei Han; Yong-Fang Kuo; Taylor S Riall; James S Goodwin Journal: JAMA Intern Med Date: 2013-04-08 Impact factor: 21.873